BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9876623)

  • 1. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro performance of floating sustained-release capsule of verapamil.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1067-72. PubMed ID: 9876561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE
    J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and pharmaceutical evaluation of new sustained-release capsule including starch-sponge matrix (SSM).
    Shibata N; Nishumura A; Naruhashi K; Nakao Y; Miura R
    Biomed Pharmacother; 2010 May; 64(5):352-8. PubMed ID: 20006463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of formaldehyde-induced crosslinking in soft elastic gelatin capsules using near-infrared spectrophotometry.
    Gold TB; Buice RG; Lodder RA; Digenis GA
    Pharm Dev Technol; 1998 May; 3(2):209-14. PubMed ID: 9653758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of cassava starch in the formulation of gelatin capsules].
    Nduele M; Ludwig A; Van Ooteghem M
    J Pharm Belg; 1993; 48(5):325-34. PubMed ID: 8120785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA; Stach PE
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release dosage form of nitrofurantoin. Part 1. Preparation of microcapsules and in vitro release kinetics.
    Ertan G; Sarigüllü I; Karasulu Y; Erçakir K; Güneri T
    J Microencapsul; 1994; 11(2):127-35. PubMed ID: 8006759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of cross-linking parameters during production of transglutaminase-hardened spherical multinuclear microcapsules by complex coacervation.
    Dong ZJ; Xia SQ; Hua S; Hayat K; Zhang XM; Xu SY
    Colloids Surf B Biointerfaces; 2008 May; 63(1):41-7. PubMed ID: 18155888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A review on liquid-filled hard gelatin capsules].
    Ma JH; Yang M; Zeng M; Chen XM; Lan J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.